(Q38548832)

4 September 2017

title

Combination of irinotecan (CPT11) and 5-fluorouracil with an analysis of cellular determinants of drug activity (English)

1 reference

4 September 2017

1 reference

1 reference

V Pavillard

1

1 reference

4 September 2017

P Formento

2

1 reference

4 September 2017

P Rostagno

3

1 reference

4 September 2017

J L Formento

4

1 reference

4 September 2017

J L Fischel

5

1 reference

4 September 2017

M Francoual

6

1 reference

4 September 2017

M C Etienne

7

1 reference

4 September 2017

G Milano

8

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

4 September 2017

published in

Biochemical Pharmacology

1 reference

4 September 2017

volume

56

1 reference

4 September 2017

issue

10

1 reference

4 September 2017

page(s)

1315-1322

1 reference

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

Thymidylate synthase and drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

Fluorouracil: biochemistry and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

Induction of apoptosis in multi-drug resistant (MDR) human glioblastoma cells by SN-38, a metabolite of the camptothecin derivative CPT-11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900205-6

10.1016/S0006-2952(98)00205-6

7 January 2021

Identifiers

DOI

1 reference

4 September 2017

1 reference